Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CDK1 Antibodies:
anti-Mouse (Murine) CDK1 Antibodies:
anti-Rat (Rattus) CDK1 Antibodies:
Go to our pre-filtered search.
Chicken Monoclonal CDK1 Primary Antibody for IHC (fro), IHC (p) - ABIN3043663
Ren, Huang, Xu, Yang, Yang, Hu: Isoflavone lupiwighteone induces cytotoxic, apoptotic, and antiangiogenic activities in DU-145 prostate cancer cells. in Anti-cancer drugs 2015
Show all 7 Pubmed References
Human Polyclonal CDK1 Primary Antibody for IHC (p), WB - ABIN3043473
Zheng, Liu, Liu, Ma, Zhou, Chen, Chang, Wang, Yang, He: Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SH?SY5Y human neuroblastoma cells. in Molecular medicine reports 2014
Show all 6 Pubmed References
Human Polyclonal CDK1 Primary Antibody for WB - ABIN3042681
Ye, Chen, Chen, Xie, Yang, Lou, Yu: XJW20, a novel oxoindole derivative, induces G2/M arrest and apoptosis selectively in K562 leukemia cell line. in Chemico-biological interactions 2009
Show all 6 Pubmed References
Human Monoclonal CDK1 Primary Antibody for WB - ABIN3043757
Lin, Fu, Zhao, Lin, Zou, Liu, Zhu, Wang, Yu: Fbxw8 is involved in the proliferation of human choriocarcinoma JEG-3 cells. in Molecular biology reports 2011
Show all 6 Pubmed References
Human Monoclonal CDK1 Primary Antibody for IHC (f), IF - ABIN967704
Barboule, Lafon, Chadebech, Vidal, Valette: Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. in FEBS letters 1999
Show all 5 Pubmed References
Human Monoclonal CDK1 Primary Antibody for IHC (f), IF - ABIN967705
García, Camacho, Morente, Fraga, Montalbán, Alvaro, Bellas, Castaño, Díez, Flores, Martin, Martinez, Mazorra, Menárguez, Mestre, Mollejo, Sáez, Sánchez, Piris: Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. in Blood 2003
Show all 5 Pubmed References
Human Polyclonal CDK1 Primary Antibody for FACS, IF (p) - ABIN669891
Haolong, Du, Hongchao, Yang, Wei, Hua, Wenliang, Lei, Po: Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells. in PLoS ONE 2013
Show all 4 Pubmed References
Human CDK1 Primary Antibody for IHC - ABIN965827
Ukomadu, Dutta: Inhibition of cdk2 activating phosphorylation by mevastatin. in The Journal of biological chemistry 2003
Show all 4 Pubmed References
Human Polyclonal CDK1 Primary Antibody for IHC - ABIN965830
Morris, Gondeau, Tainer, Divita: Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk. in The Journal of biological chemistry 2002
Show all 4 Pubmed References
Human Monoclonal CDK1 Primary Antibody for IHC (p), IP - ABIN1742575
Kobayashi, Stewart, Poon, Adamczewski, Gannon, Hunt: Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits. in Molecular biology of the cell 1993
Show all 3 Pubmed References
Cdk1 waves are not controlled by the mitotic switch but by a double-negative feedback between Cdk1 and Chk1 (show CHEK1 Antibodies). In Drosophila embryos, Cdk1 positive feedback serves primarily to ensure the rapid onset of mitosis, while wave propagation is regulated by S phase events.
Cdk1 phosphorylates the conserved centriole protein Sas-4 during mitosis. This creates a Polo (show PLK1 Antibodies)-docking site that helps recruit Polo (show PLK1 Antibodies) to daughter centrioles.
Our results indicate that the cyclic changes in Gwl (show MASTL Antibodies) localization at mitotic entry and exit are directly regulated by the antagonistic cyclin B-Cdk1 and PP2A (show PPP2R2B Antibodies)-Tws enzymes
Cdk1 mediates the role of TARA (show TRIOBP Antibodies) and CycA (show CCNA2 Antibodies) in sleep regulation.
Y15 phosphorylation can both inhibit Cdk1 catalytic activity and de-stabilize Cdk1/Cyclin (show PCNA Antibodies) complexes, whereas T161 phosphorylation facilitates stable interactions between cyclin B and Cdk1.
Phosphorylation of Cdk1 on Y15 appeared to be crucial for developmental and DNA damage-induced G2-phase checkpoint arrest, consistent with other evidence that Myt1 (show MYT1 Antibodies) is the major Y15-directed Cdk1 inhibitory kinase at this stage of development.
nonmuscle myosin II regulation by Cdc2 activity
CDK1 activation may be the cell cycle regulated event that determines the timing of emi1 destruction.
Data show that down-regulation of Cdc2 delayed pI mitosis and altered the polarity and the number of subsequent cell divisions.
Data suggest that Cks30A interacts with Cdk1, and may regulate Cyclin A (show CCNA2 Antibodies) levels through the activity of a female germline-specific anaphase-promoting complex, CDC20 (show CDC20 Antibodies)-Cortex.
FOXM1 (show FOXM1 Antibodies) may play a central role in the skp2-cdk1 loop driving tumor progression.
TRAP1 (show TRAP1 Antibodies) is relevant in the control of key cell cycle regulators in tumor cells. TRAP1 (show TRAP1 Antibodies)/TBP7 (show PSMC4 Antibodies) quality control of CDK1 and MAD2 (show MAD2L1 Antibodies) contributes mechanistically to the regulation of mitotic entry and transit.
The Vgll4 (show VGLL4 Antibodies) is phosphorylated in vitro and in vivo by cyclin-dependent kinase 1 (CDK1) during antimitotic drug-induced mitotic arrest and also in normal mitosis.
Cdk-dependent phosphorylation of TRF1 on threonine 371 promotes TRF1 to interact with APBs in S and G2 phases independently of its binding to telomeric DNA. We have demonstrated that the interaction of (pT371)TRF1 with APBs is dependent upon ATM and homologous-recombination-promoting factors such as Mre11 and BRCA1.
XIAP (show XIAP Antibodies) is stable during mitotic arrest, but its function is controlled through phosphorylation by the mitotic kinase CDK1-cyclin-B1 (show CCNB1 Antibodies) at S40.
Results suggest that the cyclin-dependent kinase I (CDK1) phosphotyrosine (pTyr15) protein is a potential indicator of the progression of colorectal cancer.
These results suggest that inhibition of CDK-1 in G2 causes unpredicted effects in mitosis, even after CDK-1 inhibition is relieved.
Date show that when Wee1 (show WEE1 Antibodies) alone is inhibited, Chk1 (show CHEK1 Antibodies) suppresses CDC45 (show CDC45 Antibodies) loading and thereby limits the extent of unscheduled replication initiation and subsequent S-phase DNA damage, despite very high CDK (show CDK4 Antibodies)-activity.
CDK1 is a positive regulator of the IFN signaling pathway. The overexpression of CDK1 might contribute to the abnormally amplified type I IFN signaling in systemic lupus erythematosus.
the mechanism of Plk1 (show PLK1 Antibodies) activation and the potential role of Bora phosphorylation by Cdk1, is reported.
Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 (show CD44 Antibodies) and RHAMM (show HMMR Antibodies)-mediated signalling pathways involving Cdc2 and gamma-adducin (show ADD3 Antibodies).
loss of LAR (show PTPRF Antibodies) activity resulted in reduced activity of CDK1.
Cdk1-induced desmin (show DES Antibodies) phosphorylation is required for efficient separation of desmin (show DES Antibodies)-IFs and generally detected in muscular mitotic cells in vivo.
using in vitro dephosphorylation assays, we demonstrate that Mastl (show MASTL Antibodies) promotes persistent MPS1 phosphorylation by inhibiting PP2A (show PPP2R2B Antibodies)/B55 (show MINK1 Antibodies)-mediated MPS1 dephosphorylation rather than affecting Cdk1 kinase activity. Our findings establish a key regulatory function of the Greatwall (show MASTL Antibodies) kinase/Mastl (show MASTL Antibodies) - PP2A (show PPP2R2B Antibodies)/B55 (show MINK1 Antibodies) pathway in preventing premature SAC (show ADCY10 Antibodies) silencing
oxidative stress-induced (show SQSTM1 Antibodies) DNA damage of mouse zygotes triggers the cell cycle checkpoint, which results in G2/M cell cycle arrest, and that phospho-Cdc25B (show CDC25B Antibodies) (Ser323), phospho-Cdc25C (show CDC25C Antibodies) (Ser216), and phospho-Cdc2 (Tyr15) participate in activating the G2/M checkpoint.
CDK1 is required upstream of a checkpoint-associated cell death as well as meiotic metaphase progression in mouse spermatocytes.
CDK1 is a synthetic lethal target for KRAS mutant tumors.
Our data demonstrate that ES cells are uniquely sensitive to CDK1 inhibition via a p53 (show TP53 Antibodies)/NOXA (show PMAIP1 Antibodies)/MCL1 (show MCL1 Antibodies) pathway.
Ubiquitin-dependent degradation of GATA 2 (show GATA2 Antibodies) is promoted by Fbw7 (show FBXW7 Antibodies), is cyclin B-CDK1-mediated Thr176 phosphorylation-dependent, and influences hematopoietic cell differentiation.
HDAC3 (show HDAC3 Antibodies) controls G2/M phase progression mainly through posttranslational stabilization of the G2/M cyclin-dependent kinase 1.
intestinal clock controls the expression of key cell cycle regulators, such as cdc2, wee1 (show WEE1 Antibodies), p21 (show CDKN1A Antibodies), PCNA (show PCNA Antibodies) and cdk2 (show CDK2 Antibodies), but only weakly influences cyclin B1 (show CCNB1 Antibodies), cyclin B2 (show CCNB2 Antibodies) and cyclin E1 (show CCNE1 Antibodies) expression.
CDK7 (show CDK7 Antibodies) and CCNH (show CCNH Antibodies) activate CDC2 by T161 phosphorylation and make up CDK-activating kinase (show CDK7 Antibodies), which is required for normal meiotic progression during porcine oocyte maturation.
Results describe the expression of maternal cyclin B1 (show CCNB1 Antibodies) and Cdc2 during in vitro maturation of porcine oocytes.
Data demonstrate the presence of a novel structure in the cortex of porcine oocytes that comprises ERES and transiently accumulates CDC2 prior to germinal vesicle breakdown.
insufficient amount of Cdc2 and continuous activation of Wee1 B are the cause of meiotic failure of small oocytes in pigs
These results suggest that the inhibitory phosphorylation of CDC2, which is catalyzed by pigWee1B (show WEE2 Antibodies), but not pigMyt1, is involved in the meiotic arrest of porcine oocytes.
the fine-tuning of Cdc6 (show CDC6 Antibodies) accumulation is essential to ensure two meiotic waves of Cdk1 activation and to avoid unscheduled DNA replication during meiotic maturation.
equilibrium between CDK1 and PP2A (show PPP2R2B Antibodies) specifies the timing of M-phase entry and exit and regulates the dynamics of cyclin B degradation upon M-phase exit in Xenopus laevis first embryonic mitosis.
CDK1 activation proceeds with concomitant inhibition by CDC6 (show CDC6 Antibodies), which tunes the timing of the M-phase entry during the embryonic cell cycle
Xenopus Cdk1-AS rescues HT2-19 cells from apoptosis.
Ras suppresses cyclin-dependent kinase 1 in a complex manner: It induces continuous accumulation of cyclin B2 (show CCNB2 Antibodies), but also causes persistent inhibitory phosphorylation of tyr (show TYR Antibodies)-15-cyclin-dependent kinase 1.
By promoting CtIP (show RBBP8 Antibodies)-dependent resection of double-strand break (DSB) ends while preventing Rad51 chromatin assembly, Cdk1 inhibits both the nonhomologous and homologous modes of DSB repair during mitosis.
Examination of H1 histones reveals isoform-specific regulation by Cdk1 and RanGTP; mitotic Cdk1 functions to enhance H1 binding in egg extracts and embryos
Cdc2 displays cytoskeleton-dependent localization in blastomere cortex during Xenopus embryonic cell cycle.
Results suggest that the specific synthesis of either B-type cyclins or c-Mos (show MOS Antibodies), induced by progesterone, is required to induce meiotic maturation and Cdc2 activation.
Cyclin B dissociation from CDK1 precedes cyclins B degradation upon CDK1 inactivation in mitotic embryo extracts and that proteasome proteolytic activity is dispensable for both activation and inactivation of CDK1 in such extracts.
Data show that phosphatidylcholine (PC) biosynthesis is repressed by disruption of the core cell cycle regulator CYCLIN-DEPENDENT KINASE A;1 (CDKA;1) and that this repression is reliant on PHOSPHATIDIC ACID PHOSPHOHYDROLASE (PAH).
Cyclin-dependent kinase A (CDKA) phosphorylates eukaryotic initiation factor 4A (show DDX39 Antibodies) (eIF4A)eIF4A1 (show EIF4A1 Antibodies) and eIF4A2 (show EIF4A2 Antibodies) on a conserved threonine residue (threonine-164) within the RNA-binding motif.
CDKA;1 and CYCD3;2 are required for the terminal division in the stomatal lineage.
Data indicate that the in vivo confirmation of substrates of CDKA;1 showing a direct link between cell proliferation and the control of the redox state.
The crucial function of CDKA;1 is the control of the plant Retinoblastoma homolog RBR1 and codepletion of RBR1 and CDKA;1 rescued most defects of cdka;1 mutants.
Expression of a dominant negative CDKA;1 allele under the control of the STM (show SHMT1 Antibodies) promoter perturbs post-embryonic development. Inhibition of CDK (show CDK4 Antibodies) activity at the shoot apex (show APEX1 Antibodies) results in premature differentiation of shoot apical meristem cells.
When a single cdka;1 sperm was delivered, either female gamete could be fertilized leading to similar proportions of seeds containing either a single endosperm or a single embryo.
However, we show here that the DNA damage checkpoint in Arabidopsis can also operate independently of the phosphorylation of CDKA;1.
CDC2A participates in the fertilization process of endosperm
The balance between cell division and differentiation is regulated through the interaction between CDKA;1 and the antiphosphatase PAS2. [CDKA;1]
These results reveal a crucial and conserved role of phosphorylation of the N terminus of Bora for Plk1 (show PLK1 Antibodies) activation and mitotic entry.
CDK-1 regulates PLK-1 (show PLK1 Antibodies) activity during mitosis in C. elegans embryos through multisite phosphorylation of the PLK-1 (show PLK1 Antibodies) activator SPAT (show AGXT Antibodies)-1
Conversion of microtubule-organizing center state involves the conserved C. elegans centrosome protein SPD-2/CEP192 and cell-cycle-dependent kinase activity from the mitotic cell.
Our results support a model in which CYB (show CSTB Antibodies)-2.1/2/CDK-1 antagonize CUL-2 (show CUL2 Antibodies) activity to promote stabilization of PAR-6 (show PARD6A Antibodies) levels during polarization of the early C. elegans embryo.
CDK-1 activates PLK-1 (show PLK1 Antibodies) via SPAT (show AGXT Antibodies)-1 phosphorylation to promote entry into mitosis.
model in which Wnt signaling and CDK-1 modify WRM-1 in a temporal and spatial manner to unmask an intrinsic polarity cue required for proper orientation of the endomesoderm cell division axis
results indicate that CDC-25.1 is required for maintaining proper rate of germline mitotic cell cycle; propose that CDC-25.1 regulates the rate of germline mitotic cell cycle by counteracting WEE (show WEE1 Antibodies)-1.3 and by positively controlling CDK-1
CDK-1 blocks rotation by inhibiting dynein association with microtubules.
Use of loss- and gain-of-function genetic approaches demonstrates that CYY-1, a cyclin (show PCNA Antibodies) box-containing protein, drives synapse removal in this process.
NPP-16 and CDK-1 function to arrest prophase blastomeres in C. elegans embryos
The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G1/S and G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
cell cycle controller CDC2
, cell division control protein 2 homolog
, cell division cycle 2, G1 to S and G2 to M
, cell division protein kinase 1
, p34 protein kinase
, cyclin-dependent kinase 1
, cell cycle p34 CDC2 kinase protein
, cell division cycle 2 homolog A
, cell division cycle control protein 2a
, Cell division cycle control protein 2
, cell division cycle 2
, Cell division control protein 2 homolog 1
, cell division control protein 2-A
, cell division cycle 2 like
, cell division protein kinase 1-A
, cyclin-dependent kinase 1-A
, p34 protein kinase 1
, cdc2 kinase
, cyclin dependent kinase
, cyclin-dependent kinase
, cell division cycle 2 protein
, protein cdc2 kinase
, putative cyclin-dependent kinase A family protein
, cell division control protein 2 homolog 2
, cell division control protein 2-B
, cell division protein kinase 1-B
, cyclin-dependent kinase 1-B
, p34 protein kinase 2
, DNA polymerase delta
, DNA-directed DNA polymerase delta 1
, polymerase (DNA directed), delta 1, catalytic subunit 125kDa
, Cell division control protein 2 homolog
, Cell division protein kinase 1
, Cell division control protein 2